General
COVID lives updates: South Korea resumes use of AstraZeneca vaccine for people under 60 after blood clot concerns
South Korea resumes use of AstraZeneca vaccine
South Korea says it will resume administrating AstraZeneca’s COVID-19 vaccine to all eligible people between the ages of 30 and 60.
Last week, it suspended the use of the vaccine for people under 60 while awaiting the outcome of the European Medicine Agency’s review.
The EMA said it had found a possible link between AstraZeneca’s COVID-19 vaccine and rare blood clotting issues in adults (you can read more on that here).
The Korea Disease Control and Prevention Agency now says it will restart the use of AstraZeneca vaccine beginning Monday, citing studies showing that the vaccine’s benefits outweighs the risk of side effects.
An agency statement said people under 30 will be…
-
Noosa News5 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
Noosa News11 hours agoFarmer Fred Perry’s 30-year conservation project creates bird haven after years of ‘bashing and burning’
-
General11 hours agoBoy dies after being trapped between rocks off NSW beach
-
Noosa News11 hours agoDetectives continue to search for answers on Crystal Beale’s death